Showing results (71-80 of 121) with videos related to

Sort By:
Pageof 13
British Journal of Cancer|November 1, 2018
Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinomaBenjamin Goeppert, Stephanie Roessler, Marcus Renner, et al.
European Journal of Cancer (Oxford, England : 1990)|April 15, 2022
Pembrolizumab and maraviroc in refractory mismatch repair proficient/microsatellite-stable metastatic colorectal cancer - The PICCASSO phase I trialGeorg Martin Haag, Christoph Springfeld, Barbara Grün, et al.
Scientific Reports|March 15, 2019
Prognostic Impact of Carboxylesterase 2 in CholangiocarcinomaBenjamin Goeppert, Marcus Renner, Stephan Singer, et al.
Future Oncology (London, England)|May 7, 2020
NUC-1031/cisplatin versus gemcitabine/cisplatin in untreated locally advanced/metastatic biliary tract cancer (NuTide:121)Mairéad Geraldine McNamara, Lipika Goyal, Mark Doherty, et al.
Cancers|September 8, 2019
RNA-Based Detection of Gene Fusions in Formalin-Fixed and Paraffin-Embedded Solid Cancer SamplesMartina Kirchner, Olaf Neumann, Anna-Lena Volckmar, et al.
Diagnostic Pathology|May 10, 2019
Low frequency of mismatch repair deficiency in gallbladder cancerBenjamin Goeppert, Stephanie Roessler, Marcus Renner, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|March 12, 2020
Metastatic adult pancreatoblastoma: Multimodal treatment and molecular characterization of a very rare diseaseAnne Katrin Berger, Sadaf Shabbir Mughal, Michael Allgäuer, et al.
BMC Cancer|December 7, 2019
HER2 gene (ERBB2) amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesisThomas Albrecht, Melina Rausch, Stephanie Rössler, et al.
Pageof 13